Become A Featured Company

Speakeasy Looks to Expand into German Market

Ryan Allway

June 19th, 2018

Exclusive, News

The global cannabis industry could reach nearly $60 billion by 2027, according to Arcview Market Research, driven by the ongoing legalization of cannabis around the world. While North America has pioneered legalization among G20 nations, many parts of Europe have taken a pro-cannabis stance that could yield an enormous long-term market. Investors may want to take a look at companies focused on this area for potential opportunities.

Speakeasy Cannabis Club Ltd. (CSE: EASY) (FFT: 39H), a late-stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) represents a compelling opportunity to invest in Europe’s burgeoning cannabis industry.

Europe’s $60B Opportunity

The European medical cannabis market could be worth about €50 billion, or about $59 billion, once all markets have implemented legislation and market infrastructure to support cannabis, according to Prohibition Partners’ European Cannabis Report. Germany, Poland, and the Netherlands have the most advanced cannabis markets in the region, but the report’s authors note that many other markets are following in their footsteps.

While many European countries are exploring cultivation, the majority of the region’s supply comes from Canada, where cannabis enjoys federal legalization. The good news is that cannabis-based drugs have been seeing steady support, including GW Pharmaceuticals’ (NASDAQ: GWPH) Sativex, while cannabis flower and oils have been legalized in several countries for patients that suffer from approved medical conditions.

Germany became Europe’s largest market in March of last year after it introduced new legislation and ten production licenses. The country’s system is geared towards partnering with international companies, such as those in Canada, that offer vast experience in a new market. From Germany, these companies could then export to other countries where cannabis has been legalized across the European Union given the trade agreements that are already in place.

Speakeasy Looks to Germany

Speakeasy Cannabis Club recently announced a memorandum of understanding with HerbaMedica GmbH to export premium cannabis to Germany and European markets. Under the terms of the deal, HerbaMedica will purchase and distribute a fixed amount of product each year from Speakeasy for an initial three year period. HerbaMedica will cover the external costs for the inspection of Speakeasy facilities by Germany authorities.

“By having HerbaMedica distribute our products throughout the EU, we gain access to a significant amount of possible clientele,” said Speakeasy CEO Marc Geen in the press release announcing the memorandum of understanding with HerbaMedica. “Currently, there are only seven approved cannabis importers to Germany, Speakeasy is excited to be an applicant for this opportunity to join this group of selected few.”

By taking a craft cannabis approach, the company aims to appeal to Millennial recreational buyers in Canada and patients looking for precise dosing and unique delivery methods in Canada and European markets. Once it secures its license from Health Canada, the company plans to develop a cannabis campus that houses five craft growers with individual identities and genetics on about 300 acres of land in the “Napa Valley of Weed”.

Looking Ahead

Speakeasy Cannabis Club Ltd. (CSE: EASY) (FFT: 39H) represents a compelling investment opportunity in the global cannabis industry. In addition to its innovative craft approach, the company’s recent deal to expand into Germany and European markets represents a compelling growth opportunity over the long-term. Investors may want to take note as the company moves closer to securing a license to become a licensed producer.
For more information, visit the company’s website at www.speakeasygrowers.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading